Adderall is a prescription. That is what makes this hard to talk about. The person you are worried about may have started with a legitimate prescription, or may have been taking pills that were prescribed to someone else, and either way the pills came from a pharmacy, not a street corner. It can feel like it should not count.
It counts. This guide explains what prescription stimulants are, what stopping them feels like, when medically supervised withdrawal management in the Cleveland area is the right call, and what happens after. It is the second part of our stimulant series; the first covers how Cleveland’s overdose picture has shifted toward stimulants and what stimulant use treatment involves.
What prescription stimulants are
The U.S. Food and Drug Administration’s prescribing information states that Adderall “contains amphetamine, a Schedule II controlled substance.” [1] The Drug Enforcement Administration defines Schedule II drugs as those “with a high potential for abuse, with use potentially leading to severe psychological or physical dependence,” and lists Adderall and Ritalin among its examples. [2]
The FDA’s own prescribing information for Adderall opens with a boxed warning: the medication “has a high potential for abuse and misuse, which can lead to the development of a substance use disorder,” and “misuse and abuse of CNS stimulants, including ADDERALL, can result in overdose and death,” a risk that “is increased with higher doses or unapproved methods of administration, such as snorting or injection.” [1]
None of that means a person with a prescription is doing something wrong by taking it. It means the medication is one that can be misused, and that when it is, the consequences are serious enough that stopping deserves medical attention.
How common misuse is
The 2024 National Survey on Drug Use and Health found that “1.4 percent of people aged 12 or older (or 3.9 million people) misused prescription stimulants in the past year.” [3] Among young adults aged 18 to 25, past-year misuse “declined from 4.1 percent (or 1.4 million people) in 2021 to 2.8 percent (or 973,000 people) in 2024.” [3]
That is a large number of people, and most of them are not the stereotype anyone has in mind. Students, shift workers, parents, people with an old prescription and a stressful year. If that describes someone you love, the questions below are for you.
What Adderall withdrawal looks like
The FDA label lists what happens when someone stops after prolonged use. “Withdrawal signs and symptoms after abrupt discontinuation or dose reduction following prolonged use of CNS stimulants including ADDERALL include dysphoric mood; depression; fatigue; vivid, unpleasant dreams; insomnia or hypersomnia; increased appetite; and psychomotor retardation or agitation.” [4]
The federal treatment guidance for stimulant use disorders, SAMHSA’s TIP 33, describes the same arc in two phases. Acute withdrawal “is characterized by dysphoria, anxiety, and agitation and can begin a short time after cessation of stimulant use,” and that period “is characterized by a profound hypersomnolence, fatigue, mood lability, and increased appetite.” [5] After the acute phase, “the person may experience symptoms that are opposite to those of stimulant intoxication: fatigue, loss of physical and mental energy, depression, anhedonia, and a limited interest in his or her surroundings.” [5]
Those later symptoms do not clear in a weekend. The current clinical practice guideline on stimulant use disorder from the American Society of Addiction Medicine and the American Academy of Addiction Psychiatry notes that “post-acute symptoms of stimulant withdrawal—which include depression, anxiety, insomnia, and paranoia—can last for weeks to months.” [6]
The risk that makes supervision matter
Stimulant withdrawal is different from alcohol or opioid withdrawal. TIP 33 notes that “no consistent physiologic disruptions requiring gradual withdrawal have been observed,” and that “medication management of withdrawal symptoms has not been well established in major clinical trials.” [5] So the reason for supervision is not a seizure risk or a tapering schedule.
The reason is mood. TIP 33 states that “because withdrawal-related dysphoria and depression can be particularly severe in people using stimulants, risk of suicide is intensified and sensitive management is essential,” and that “in the first 1–2 weeks of withdrawal from stimulants, some patients may experience suicidality and should be monitored appropriately.” [5] The ASAM and AAAP guideline says the same thing in its own terms: clinicians “should monitor for progression of psychiatric symptoms, breakthrough psychosis, suicidality, and emergence of trauma-related symptoms; in particular, suicidality may increase during waning intoxication and acute withdrawal.” [6]
If someone is having thoughts of suicide, that is an emergency. The 988 Suicide and Crisis Lifeline is available 24 hours a day by call or text, and 911 is the right call if someone is in immediate danger.
That window, the first days and weeks after stopping, is exactly when a person is most likely to feel hopeless and most likely to start again. 24/7 nursing support is in place through this window.
What medically supervised detox involves here
Olympia Grove Recovery provides medically supervised withdrawal management, what most people call medical detox, in Euclid, with 24/7 nursing support. Nurses monitor the person’s sleep, appetite, mood, and physical symptoms through the crash. Qualified medical providers evaluate medication needs, which for stimulant withdrawal usually means treating the symptoms that make the days hard, such as sleep and mood, and watching closely for the risks described above.
The ASAM and AAAP guideline makes the same point in its key takeaways: treating the symptoms of stimulant withdrawal may help support a person’s ongoing engagement in treatment. [6] That is the goal of this phase. Not a finish line, and not a fixed number of days, but a safe, supported start that makes the next step possible. Length of stay is determined by medical necessity.
Two things to know about the medical side. First, if a person has been using a prescription stimulant alongside other substances, the medical team evaluates the other substances involved, because the safe plan depends on the whole picture. Second, because prescription stimulants are also legitimate medicines, prescribing decisions belong to medical providers, not to marketing copy. Bring the bottle and the prescriber’s name.
When residential treatment follows
Withdrawal management is the first step, not the whole plan. The guideline’s point about weeks-to-months of low mood, anxiety, and disrupted sleep is the reason residential treatment usually follows: the person needs structure and support through the period when starting again is most tempting.
Residential treatment at Olympia Grove Recovery means the person lives at the recovery center while in care. Days are built around individual and group therapy, and the clinical team’s approach draws on cognitive behavioral therapy and an introduction to dialectical behavior therapy skills, along with motivational interviewing. Care addresses co-occurring mental health conditions where they are present, and family therapy is available where a family can take part.
Ohio Medicaid, commercial insurance, and private pay are accepted. Coverage depends on your specific plan. Have the member ID handy. Coverage check happens on the call.
The Cleveland picture
Cuyahoga County’s overdose numbers are the reason this series exists. The county Board of Health’s 2025 Drug Overdose Integrated Epidemiologic Profile, dated August 2026, reports that “in 2024, there were 353 unintentional drug overdose deaths” among county residents, and that “in 2024, fentanyl and fentanyl analogues were involved in 73%” of them. [7] From 2023 to 2024, overdose deaths related to psychostimulants “decreased 19%, both with and without the presence of opioids.” [7]
The preliminary numbers for the first half of 2025 tell a different story. The same profile reports that for January through June 2025, “after cocaine (N = 102), fentanyl and fentanyl analogues (N = 73) remain a major contributor,” and that “this is the first year that fentanyl and fentanyl analogues have not been the leading drug type associated with” overdose deaths in the county. [7] The profile is explicit that those 2025 figures cover only the first six months and are “preliminary and incomplete.” [7]
Two things follow for a family in the Cleveland area. First, stimulants are not a side issue here. Second, what a person believes they took and what they actually took are often different, which is what the assessment is for. If an overdose is happening, that is a medical emergency. Call 911.
Frequently asked questions
Is Adderall withdrawal dangerous? It is different from alcohol or opioid withdrawal. Federal guidance notes that “no consistent physiologic disruptions requiring gradual withdrawal have been observed.” The danger is psychological: severe low mood, and in some people suicidal thinking in the first one to two weeks. That is why monitoring matters. If someone is having thoughts of suicide, call or text 988; call 911 if they are in immediate danger.
How long does Adderall withdrawal last? The acute crash begins a short time after stopping. Post-acute symptoms such as depression, anxiety, insomnia, and paranoia “can last for weeks to months.” That is a description of withdrawal, not of a treatment stay; length of stay at Olympia Grove Recovery is determined by medical necessity.
Is there a medication for stimulant withdrawal? Federal guidance says medication management of stimulant withdrawal symptoms “has not been well established in major clinical trials.” At Olympia Grove Recovery, qualified medical providers evaluate each person’s medication needs and treat the symptoms that make the days hard. Medication decisions belong to the medical team, not to a web page.
My family member has a real ADHD prescription. Does that change things? It means the assessment matters even more. Bring the bottle and the prescriber’s name. A current prescription is part of the clinical picture, and prescribing decisions belong to medical providers, not to a web page.
Does Olympia Grove Recovery treat prescription stimulant use, or only cocaine and meth? Both. Olympia Grove Recovery has a medical detox page specific to Adderall, and the same medically supervised withdrawal management and residential treatment apply to prescription stimulants, cocaine, and methamphetamine. What differs is the assessment, which is why it comes first.
Does Ohio Medicaid cover detox for a prescription stimulant? Ohio Medicaid covers substance use disorder treatment, including withdrawal management and residential care. What your specific plan pays depends on the plan. Have the member ID handy. Coverage check happens on the call.
What to do next
If someone you love is misusing Adderall or another prescription stimulant and stopping has been harder than it should be, call admissions at 216.438.8351. Admissions answers 24/7. Have the member ID handy. Coverage check happens on the call. If someone is in immediate danger, call 911.
Olympia Grove Recovery · 19350 Euclid Avenue, Euclid, OH 44117 · Accredited by The Joint Commission · Ohio Department of Behavioral Health license 01-8590
Sources
- U.S. Food and Drug Administration, ADDERALL prescribing information (revised 10/2023), Boxed Warning and Drug Abuse and Dependence section. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf
- U.S. Drug Enforcement Administration, “Drug Scheduling.” https://www.dea.gov/drug-information/drug-scheduling
- Substance Abuse and Mental Health Services Administration, “Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health.” https://www.samhsa.gov/data/sites/default/files/reports/rpt56287/2024-nsduh-annual-national/2024-nsduh-annual-national-html-071425-edited/2024-nsduh-annual-national.htm
- U.S. Food and Drug Administration, ADDERALL prescribing information (revised 10/2023), section 9.3, Dependence. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf
- Substance Abuse and Mental Health Services Administration, “Treatment for Stimulant Use Disorders: Updated 2021,” TIP 33, Chapter 3, Medical Aspects of Stimulant Use Disorders. https://www.ncbi.nlm.nih.gov/sites/books/n/tip33v2/ch3/
- American Society of Addiction Medicine and American Academy of Addiction Psychiatry, “Clinical Practice Guideline on the Management of Stimulant Use Disorder” (2024), Key Takeaway 6 and Recommendation 62. https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/quality-science/stud_guideline_document_final.pdf
- Cuyahoga County Board of Health, “2025 Cuyahoga County Drug Overdose Integrated Epidemiologic Profile” (August 2026). https://ccbh.net/wp-content/uploads/2026/09/2025-Cuyahoga-County-DOIEP.pdf